共 10 条
[1]
Van Damme L., Corneli A., Ahmed K., Agot K., Lombaard J., Kapiga S., Malahleha M., Owino F., Manongi R., Onyango J., Temu L., Monedi M.C., Mak'Oketch P., Makanda M., Reblin I., Makatu S.E., Saylor L., Kiernan H., Kirkendale S., Wong C., Grant R., Kashuba A., Nanda K., Mandala J., Fransen K., Deese J., Crucitti T., Mastro T.D., Taylor D., Preexposureprophylaxis for HIV infection among African women, N Engl J Med, 367, pp. 411-422, (2012)
[2]
Marrazzo J.M., Ramjee G., Richardson B.A., Gomez K., Mgodi N., Nair G., Palanee T., Nakabiito C., van der Straten A., Noguchi L., Hendrix C.W., Dai J.Y., Ganesh S.B., Taljaard M., Parikh U.M., Piper J., Masse B., Grossman C., Rooney J., Schwartz J.L., Watts H., Marzinke M.A., Hillier S.L., McGowan I.M., Chirenje Z.M., Tenofovir-based preexposure prophylaxis for HIV infection among African women, N Engl J Med, 372, pp. 509-518, (2015)
[3]
Patterson K.B., Prince H.A., Kraft E., Jenkins A.J., Shaheen N.J., Rooney J.F., Cohen M.S., Kashuba A.D., Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission, Sci Transl Med, 3, (2011)
[4]
Hillier S.L., Meyn L.A., Bunge K., Impact of vaginal microbiota on genital tissue and plasma concentrations of tenofovir. Presented at: CROI, (2017)
[5]
Baeten J.M., Palanee-Phillips T., Brown E.R., Schwartz K., Soto-Torres L.E., Govender V., Mgodi N.M., Matovu Kiweewa F., Nair G., Mhlanga F., Siva S., Bekker L.G., Jeenarain N., Gaffoor Z., Martinson F., Makanani B., Pather A., Naidoo L., Husnik M., Richardson B.A., Parikh U.M., Mellors J.W., Marzinke M.A., Hendrix C.W., van der Straten A., Ramjee G., Chirenje Z.M., Nakabiito C., Taha T.E., Jones J., Mayo A., Scheckter R., Berthiaume J., Livant E., Jacobson C., Ndase P., White R., Patterson K.,
[6]
Annalene Nel M.B., Ch.B., Ph.D., Cynthia Gama, M.B., Ch.B., Katherine Gill, M.B., Ch.B., Anatoli Kamali, M.B., Ch.B., Ph.D., Philip Kotze, M.B., Ch.B., M.Med., Cheryl Louw, M.B., Ch.B., Zonke Mabude, M.A., Nokuthula Miti, M.B., Ch.B., Sylvia Kusemererwa, M.B., Ch.B., M.P.H., Hugo Tempelman, M.D., Hannelie Carstens, Ph.D., Brid Devlin, Ph.D., Michelle Isaacs, B.Pharm., B.Sc., Mariëtte Malherbe, B.Sc., Winel Mans, M.B., Ch.B., Jeremy Nuttall, M.Sc., Marisa Russell, B.Sc., Smangaliso Ntshele, Dip.
[7]
375:2133-2143December, (2016)
[8]
Riddler S., Balkus J., Mellors J., Parikh U., Akello C., Dadabhai S., Mhlanga F., O'Rourke C., Seattle, WA
[9]
February 13-16, 2017, Abstract, (2017)
[10]
Gulick R., Wilkin T., Chen Y., HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in United States (U.S.) women. Presented at: 21st International AIDS Conference (AIDS 2016), (2016)